课题基金 / 基金详情

MPROS- MOBILE PRO-CTCAE ADMINISTRATION SYSTEM FOR POST-RADIATION TOXICITIES

MPROS- MOBILE PRO-CTCAE ADMINISTRATION SYSTEM FOR POST-RADIATION TOXICITIES
MPROS- 辐射后毒性移动 PRO-CTCAE 管理系统
批准号:
10276304
负责人:
JODY UNDERWOOD
金额:
$150.0万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-15 至 2022-09-14

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
MPROS是一款以患者为中心的智能手机应用程序,允许患者轻松报告放射和化疗治疗引起的症状。MPROS为临床医生提供了获取患者信息的途径,这些信息可用于及时调整治疗。最终,mPROS将被集成到电子健康记录(EHR)系统中,使临床医生能够无缝地获取患者报告的结果。据推测,这种个性化的症状报告将改善患者的健康相关生活质量(HRQOL)。第二阶段研究的主要目标是证明这一益处。第二阶段将改进和改进mPROS中的用户体验和内容,然后进行一项随机临床试验,通过展示及时和个性化的症状报告可以带来更好的患者HRQOL来测试其有效性。
英文摘要
mPROS is a patient-centric smartphone app which allows patients to comfortably report symptoms that are due to radiation and chemo-radiation treatment. mPROS provides clinicians with access to patient information that can be used to make timely treatment adjustments. Ultimately, mPROS will be integrated into Electronic Health Record (EHR) systems to make it seamless for clinicians to access patient-reported outcomes. It is hypothesized this individualized symptom reporting will improve patient health-related quality of life (HRQOL). The primary objective of the Phase II study is to demonstrate this benefit. Phase II will refine and improve the user experience and the content in mPROS and then run a randomized clinical trial to test its validity by showing that timely and individualized symptom reporting can result in better patient HRQOL.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金